121 related articles for article (PubMed ID: 20347325)
1. Toxicity and phototoxicity of Hypocrellin A on malignant human cell lines, evidence of a synergistic action of photodynamic therapy with Imatinib mesylate.
Chio-Srichan S; Oudrhiri N; Bennaceur-Griscelli A; Turhan AG; Dumas P; Refregiers M
J Photochem Photobiol B; 2010 May; 99(2):100-4. PubMed ID: 20347325
[TBL] [Abstract][Full Text] [Related]
2. Photodynamic effects of hypocrellin A on three human malignant cell lines by inducing apoptotic cell death.
Zhang J; Cao EH; Li JF; Zhang TC; Ma WJ
J Photochem Photobiol B; 1998 May; 43(2):106-11. PubMed ID: 9679312
[TBL] [Abstract][Full Text] [Related]
3. Complexation of Hypocrellin A with Al3+ in water solution and the photodynamic therapy study.
Ma F; Huang H; Ge X; Yang X; Yang C; Han L; Zhou J; Zhou L
Bioorg Med Chem Lett; 2013 Mar; 23(6):1689-92. PubMed ID: 23411082
[TBL] [Abstract][Full Text] [Related]
4. A new near infrared photosensitizing nanoplatform containing blue-emitting up-conversion nanoparticles and hypocrellin A for photodynamic therapy of cancer cells.
Jin S; Zhou L; Gu Z; Tian G; Yan L; Ren W; Yin W; Liu X; Zhang X; Hu Z; Zhao Y
Nanoscale; 2013 Dec; 5(23):11910-8. PubMed ID: 24129918
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of vanadyl-hypocrellin A complex and its photodynamic properties research.
Yang C; Ma F; Tang J; Han L; Wei S; Zhou L; Zhou J; Shen J; Wang F
Bioorg Med Chem Lett; 2012 Aug; 22(15):5003-7. PubMed ID: 22749418
[TBL] [Abstract][Full Text] [Related]
6. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
[TBL] [Abstract][Full Text] [Related]
7. Combination of chemotherapy and photodynamic therapy using graphene oxide as drug delivery system.
Zhou L; Zhou L; Wei S; Ge X; Zhou J; Jiang H; Li F; Shen J
J Photochem Photobiol B; 2014 Jun; 135():7-16. PubMed ID: 24792568
[TBL] [Abstract][Full Text] [Related]
8. Graphene oxide noncovalent photosensitizer and its anticancer activity in vitro.
Zhou L; Wang W; Tang J; Zhou JH; Jiang HJ; Shen J
Chemistry; 2011 Oct; 17(43):12084-91. PubMed ID: 21915922
[TBL] [Abstract][Full Text] [Related]
9. Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.
Nguyen TK; Rahmani M; Gao N; Kramer L; Corbin AS; Druker BJ; Dent P; Grant S
Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2239-47. PubMed ID: 16609040
[TBL] [Abstract][Full Text] [Related]
10. External heavy-atomic construction of photosensitizer nanoparticles for enhanced in vitro photodynamic therapy of cancer.
Zhou L; Wei S; Ge X; Zhou J; Yu B; Shen J
J Phys Chem B; 2012 Oct; 116(42):12744-9. PubMed ID: 22984941
[TBL] [Abstract][Full Text] [Related]
11. Effect of imatinib on the signal transduction cascade regulating telomerase activity in K562 (BCR-ABL-positive) cells sensitive and resistant to imatinib.
Mor-Tzuntz R; Uziel O; Shpilberg O; Lahav J; Raanani P; Bakhanashvili M; Rabizadeh E; Zimra Y; Lahav M; Granot G
Exp Hematol; 2010 Jan; 38(1):27-37. PubMed ID: 19837126
[TBL] [Abstract][Full Text] [Related]
12. Determination of drug synergism between the tyrosine kinase inhibitors NSC 680410 (adaphostin) and/or STI571 (imatinib mesylate, Gleevec) with cytotoxic drugs against human leukemia cell lines.
Avramis IA; Laug WE; Sausville EA; Avramis VI
Cancer Chemother Pharmacol; 2003 Oct; 52(4):307-18. PubMed ID: 12827297
[TBL] [Abstract][Full Text] [Related]
13. New long-wavelength perylenequinones: synthesis and phototoxicity of hypocrellin B derivatives.
Li L; Chen Y; Shen J; Zhang M; Shen T
Biochim Biophys Acta; 2000 Sep; 1523(1):6-12. PubMed ID: 11099852
[TBL] [Abstract][Full Text] [Related]
14. Photosensitizer effects on cancerous cells: a combined study using synchrotron infrared and fluorescence microscopies.
Chio-Srichan S; Réfrégiers M; Jamme F; Kascakova S; Rouam V; Dumas P
Biochim Biophys Acta; 2008 May; 1780(5):854-60. PubMed ID: 18342635
[TBL] [Abstract][Full Text] [Related]
15. Enhanced CML stem cell elimination in vitro by bryostatin priming with imatinib mesylate.
Jørgensen HG; Allan EK; Mountford JC; Richmond L; Harrison S; Elliott MA; Holyoake TL
Exp Hematol; 2005 Oct; 33(10):1140-6. PubMed ID: 16219536
[TBL] [Abstract][Full Text] [Related]
16. Delivering a hydrophobic anticancer drug for photodynamic therapy by amorphous formulation.
Zhou L; Wang W; Feng Y; Wei S; Zhou J; Yu B; Shen J
Bioorg Med Chem Lett; 2010 Nov; 20(21):6172-4. PubMed ID: 20850314
[TBL] [Abstract][Full Text] [Related]
17. A novel photosensitizer, 2-butylamino-2-demethoxy-hypocrellin A (2-BA-2-DMHA). 1. Synthesis of 2-BA-2-DMHA and its phototoxicity to MGC803 cells.
Zhang WG; Weng M; Pang SZ; Zhang MH; Yang HY; Zhao HX; Zhang ZY
J Photochem Photobiol B; 1998 Jun; 44(1):21-8. PubMed ID: 9745725
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of ROS-NF-κB-dependent autophagy enhances Hypocrellin A united LED red light-induced apoptosis in squamous carcinoma A431 cells.
Niu T; Tian Y; Wang G; Guo G; Tong Y; Shi Y
Cell Signal; 2020 May; 69():109550. PubMed ID: 32007528
[TBL] [Abstract][Full Text] [Related]
19. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
20. The proteasome inhibitor PS-341 inhibits growth and induces apoptosis in Bcr/Abl-positive cell lines sensitive and resistant to imatinib mesylate.
Gatto S; Scappini B; Pham L; Onida F; Milella M; Ball G; Ricci C; Divoky V; Verstovsek S; Kantarjian HM; Keating MJ; Cortes-Franco JE; Beran M
Haematologica; 2003 Aug; 88(8):853-63. PubMed ID: 12935973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
